Livingston Mark S. sold $49K of PGNY
Livingston Mark S. (CHIEF FINANCIAL OFFICER) sold 1,918 shares of Progyny, Inc. (PGNY) at $25.50 on 2026-06-04 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates ownership records but does not introduce new company fundamentals; 10b5-1 pre-arranged selling reduces interpretability as a forward-looking signal.
Market read
Traders may note the insider sale for sentiment/positioning, but it is unlikely to drive a fundamental repricing by itself.
What to watch
Compare with prior Form 4 activity (frequency/size) and whether other insiders also sold around the same period; this article alone doesn’t establish trend.
Background
The filing is an SEC Form 4 insider transaction for Progyny, Inc. (PGNY).
Ticker impact
Progyny CFO Mark Livingston sold 1,918 shares in an open-market transaction under a pre-arranged 10b5-1 plan, disclosed via Form 4.
Likely limited near-term impact; any effect is more sentiment/flow-related than fundamental.
This is an ownership-change disclosure with no accompanying earnings, guidance, or operational catalyst; 10b5-1 plans are designed to be non-informational.
Market effects
None—single-company insider transaction without sector-wide news.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, repeated or sizable insider sales can coincide with internal risk management or liquidity needs; monitor for clustering of future sales.
Key entities
- issuerProgyny, Inc.
Subject of the Form 4 insider transaction; CFO Mark Livingston sold shares under a 10b5-1 plan.
- insiderLivingston Mark S.
Chief Financial Officer who executed the open-market sale.
